AgeX Therapeutics Inc.

The momentum for this stock is not very good. AgeX Therapeutics Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in AgeX Therapeutics Inc..

AgeX Therapeutics, Inc. operates as a biotechnology company. It focuses on the development and comme...

News

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AGE, GRPH, FIXX

PR Newswire SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AGE, GRPH, FIXX SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AGE, GRPH, FIXX PR Newswire NEW YORK, Feb. 27, 2024 NEW YORK, Feb. 27, 2024...\n more…

AGEX THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AgeX Therapeutics, Inc. - AGE

Business Wire Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed merger of AgeX Therapeutics, Inc. (NYSE: AGE) with...\n more…

AGEX THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AgeX Therapeutics, Inc. - AGE

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AGE, SMMF

Globe Newswire NEW YORK, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: AgeX Therapeutics, Inc. (NYSE: AGE)s merger ...\n more…

AGE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of AgeX Therapeutics, Inc. Is Fair to Shareholders

Business Wire Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of AgeX Therapeutics, Inc. (NYSE: AGE) and Serina Therapeutics, Inc. is fair to AgeX shareholders. Upon completion of the merger, pre-merger AgeX stockholders are expected to own approximately 25% of the newly...\n more…